Soluble TCR molecules and methods of use

Details for Australian Patent Application No. 2004289316 (hide)

Owner Altor Bioscience Corporation

Inventors Zhu, Xiaoyun; Belmont, Heather J.; Card, Kimberlyn F.; Price-Schiavi, Shari A.

Agent Shelston IP

Pub. Number AU-B-2004289316

PCT Pub. Number WO2005/046449

Priority 60/518,790 10.11.03 US

Filing date 10 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 31 March 2011

International Classifications

C07K 14/55 (2006.01) Peptides having more than 20 amino acids

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 51/08 (2006.01) Preparations containing radioactive substances for use in therapy or testing

C07K 14/725 (2006.01) Peptides having more than 20 amino acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/046449 Priority application(s): WO2005/046449

31 March 2011 Application Accepted

  Published as AU-B-2004289316

28 April 2011 Alteration of Name

  The name of the applicant has been altered to Altor BioScience Corporation

28 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289318-Crystalline topotecan hydrochloride product and preparation thereof

2004289315-Electrosurgical instrument